Predictive value of the Lung Immune Prognostic Index (LIPI) in locally advanced non-small-cell lung cancer (NSCLC) patients treated with concurrent chemoradiotherapy (CCRT) in the multicenter retrospective study.

被引：0
|
作者：
Oya, Yuko
Saito, Go
Tamiya, Akihiro
Kawachi, Hayato
Fujimoto, Daichi
Iwasawa, Shunichiro
Suzuki, Hidekazu
Niitsu, Takayuki
Matsumoto, Hirotaka
Miyauchi, Eisaku
Yokoi, Takashi
Mitsui, Miho
Uenami, Takeshi
Sakata, Yoshihiko
Nakachi, Ichiro
Okada, Asuka
Hara, Satoshi
Teraoka, Shunsuke
Kokubo, Masaki
机构：
[1] Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi, Japan
[2] Chiba Univ, Grad Sch Med, Dept Respirol, Chiba, Japan
[3] Natl Hosp Org Kinki Chuo Chest Med Ctr, Dept Internal Med, Sakai, Osaka, Japan
[4] Osaka Int Canc Inst, Dept Thorac Oncol, Osaka, Japan
[5] Gen Hosp, Kobe City Med Ctr, Dept Resp Med, Kobe, Hyogo, Japan
[6] Chiba Univ, Dept Med Oncol, Chiba, Japan
[7] Osaka Habikino Med Ctr, Dept Thorac Oncol, Habikino, Japan
[8] Osaka Gen Med Ctr, Dept Resp Med, Osaka, Japan
[9] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Resp Med, Amagasaki, Hyogo, Japan
[10] Tohoku Univ Hosp, Dept Resp Med, Sendai, Miyagi, Japan
[11] Hyogo Coll Med, Dept Thorac Oncol, Nishinomiya, Hyogo, Japan
[12] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama, Japan
[13] Natl Hosp Org Osaka Toneyama Med Ctr, Dept Thorac Oncol, Osaka, Japan
[14] Saiseikai Kumamoto Hosp, Div Resp Med, Kumamoto, Japan
[15] Saiseikai Utsunomiya Hosp, Internal Med, Pulm Div, Utsunomiya, Tochigi, Japan
[16] Saiseikai Suita Hosp, Dept Resp Med, Osaka, Japan
[17] Itami City Hosp, Dept Resp Med, Osaka, Japan
[18] Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan
[19] Kobe City Med Ctr, Gen Hosp, Dept Radiat Oncol, Kobe, Hyogo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21076
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The Lung Immune Prognostic Index (LIPI), a predictive score for immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC) patients
    Mezquita, L.
    Auclin, E.
    Charrier, M.
    Ferrara, R.
    Masip, J. Remon
    Planchard, D.
    Aix, S. Ponce
    Paz-Ares, L.
    Lahmar, J.
    Leroy, L.
    Audigier-Valette, C.
    Cuairan, J. Zeron-Medina
    Lopez, P. Garrido
    Brosseau, S.
    Mazieres, J.
    Caramella, C.
    Adam, J.
    Chaput, N.
    Soria, J-C.
    Besse, B.
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] The Lung Immune Prognostic Index (LIPI) stratifies prognostic groups in advanced non-small cell lung cancer (NSCLC) patients
    Aldea, Mihaela
    Benitez, Jose Carlos
    Mezquita, Laura
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (04) : 967 - 970
  • [3] NIMOTUZUMAB IN COMBINATION WITH CONCURRENT CHEMORADIOTHERAPY (CRT) IN PATIENTS WITH LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
    Satouchi, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 57 - 57
  • [4] Association between the lung immune prognostic index (LIPI) and durvalumab consolidation outcomes in patients with locally advanced non-small cell lung cancer (NSCLC)
    Melia, M. Riudavets
    Auclin, E.
    Aboubakar, F.
    Aix, S. Ponce
    Dal Maso, A.
    Bluthgen, V.
    Mielgo, X.
    Mussat, E.
    Reyes, R.
    Benitez, J.
    Lupinacci, L.
    Duchemann, B.
    de Giglio, A.
    Bautista, J.
    Audigier-Valette, C.
    Scheffler, M.
    Campayo, M.
    Besse, B.
    Planchard, D.
    Mezquita, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S1384 - S1384
  • [5] EFFICACY OF CONCURRENT CHEMORADIOTHERAPY IN LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER
    Almodovar, M.
    Ramos, H.
    Mota, P.
    Martins, V.
    Pereira, P.
    LUNG CANCER, 2011, 71 : S42 - S43
  • [6] A validation study on the lung immune prognostic index for prognostic value in patients with locally advanced non-small cell lung cancer
    Zhang, Tao
    Xue, Wenji
    Wang, Daquan
    Xu, Kunpeng
    Wu, Linfang
    Wu, Yuqi
    Zhou, Zongmei
    Chen, Dongfu
    Feng, Qinfu
    Liang, Jun
    Xiao, Zefen
    Hui, Zhouguang
    Lv, Jima
    Wang, Xin
    Deng, Lei
    Wang, Wenqing
    Liu, Wenyang
    Wang, Jianyang
    Zhai, Yirui
    Wang, Jie
    Bi, Nan
    Wang, Luhua
    RADIOTHERAPY AND ONCOLOGY, 2021, 156 : 244 - 250
  • [7] Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer
    Katayama, H
    Ueoka, H
    Kiura, K
    Tabata, M
    Kozuki, T
    Tanimoto, M
    Fujiwara, T
    Tanaka, N
    Date, H
    Aoe, M
    Shimizu, N
    Takemoto, M
    Hiraki, Y
    BRITISH JOURNAL OF CANCER, 2004, 90 (05) : 979 - 984
  • [8] Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer
    H Katayama
    H Ueoka
    K Kiura
    M Tabata
    T Kozuki
    M Tanimoto
    T Fujiwara
    N Tanaka
    H Date
    M Aoe
    N Shimizu
    M Takemoto
    Y Hiraki
    British Journal of Cancer, 2004, 90 : 979 - 984
  • [9] Phase 2 Study of Nimotuzumab in Combination With Concurrent Chemoradiotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer
    Yamamoto, Nobuyuki
    Harada, Hideyuki
    Okamoto, Isamu
    Masuda, Noriyuki
    Hayakawa, Kazushige
    Satouchi, Miyako
    Soejima, Toshinori
    Nishio, Makoto
    Kozuka, Takuyo
    Takeda, Koji
    Tanaka, Masahiro
    Seto, Takashi
    Sasaki, Tomonari
    Tsubouchi, Hiroshi
    Kakurai, Yasuyuki
    Nishimura, Yasumasa
    Nakagawa, Kazuhiko
    CLINICAL LUNG CANCER, 2021, 22 (02) : 134 - +
  • [10] Evaluation of Predictive and Prognostic Importance of Lung Immune Prognostic Index in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy
    Arikan, Rukiye
    Alkis, Hilal
    Isik, Selver
    Yasar, Alper
    celebi, Abdussamet
    Majidova, Nargiz
    Adli, Mustafa
    Sever, Nadiya
    Demircan, Nazim C.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
12345